BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28107662)

  • 1. A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
    Duan F; Feng X; Yang X; Sun W; Jin Y; Liu H; Ge K; Li Z; Zhang J
    Biomaterials; 2017 Apr; 122():23-33. PubMed ID: 28107662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation.
    Wang C; Li P; Liu L; Pan H; Li H; Cai L; Ma Y
    Biomaterials; 2016 Feb; 79():88-100. PubMed ID: 26702587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity.
    Yuba E; Yamaguchi A; Yoshizaki Y; Harada A; Kono K
    Biomaterials; 2017 Mar; 120():32-45. PubMed ID: 28027502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.
    Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y
    Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy.
    Hassan HA; Smyth L; Wang JT; Costa PM; Ratnasothy K; Diebold SS; Lombardi G; Al-Jamal KT
    Biomaterials; 2016 Oct; 104():310-22. PubMed ID: 27475727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles.
    Gao Y; Zhou Y; Zhao L; Zhang C; Li Y; Li J; Li X; Liu Y
    Acta Biomater; 2015 Sep; 23():127-135. PubMed ID: 26013038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction-Responsive Codelivery System Based on a Metal-Organic Framework for Eliciting Potent Cellular Immune Response.
    Yang Y; Chen Q; Wu JP; Kirk TB; Xu J; Liu Z; Xue W
    ACS Appl Mater Interfaces; 2018 Apr; 10(15):12463-12473. PubMed ID: 29595246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
    Raja MA; Arif M; Feng C; Zeenat S; Liu CG
    J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-conversional zwitterionic copolymer as pH-sensitive shielding system for effective tumor treatment.
    Chen J; Dong X; Feng T; Lin L; Guo Z; Xia J; Tian H; Chen X
    Acta Biomater; 2015 Oct; 26():45-53. PubMed ID: 26292265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy.
    Kim H; Sehgal D; Kucaba TA; Ferguson DM; Griffith TS; Panyam J
    Nanoscale; 2018 Nov; 10(44):20851-20862. PubMed ID: 30403212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics.
    Ujjwal RR; Purohit MP; Patnaik S; Ojha U
    ACS Appl Mater Interfaces; 2015 Jun; 7(21):11497-507. PubMed ID: 25961335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organelle-Specific Triggered Release of Immunostimulatory Oligonucleotides from Intrinsically Coordinated DNA-Metal-Organic Frameworks with Soluble Exoskeleton.
    Wang Z; Fu Y; Kang Z; Liu X; Chen N; Wang Q; Tu Y; Wang L; Song S; Ling D; Song H; Kong X; Fan C
    J Am Chem Soc; 2017 Nov; 139(44):15784-15791. PubMed ID: 29024595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.
    Au KM; Satterlee A; Min Y; Tian X; Kim YS; Caster JM; Zhang L; Zhang T; Huang L; Wang AZ
    Biomaterials; 2016 Mar; 82():178-93. PubMed ID: 26763733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
    Okazaki S; Iwasaki T; Yuba E; Watarai S
    J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive assembly of gold nanoparticles and "spatiotemporally concerted" drug release for synergistic cancer therapy.
    Nam J; La WG; Hwang S; Ha YS; Park N; Won N; Jung S; Bhang SH; Ma YJ; Cho YM; Jin M; Han J; Shin JY; Wang EK; Kim SG; Cho SH; Yoo J; Kim BS; Kim S
    ACS Nano; 2013 Apr; 7(4):3388-402. PubMed ID: 23530622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.